Charles River Laboratories International (CRL) Stock Chart & Stock Price History → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free CRL Stock Alerts $239.46 -0.67 (-0.28%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Charles River Laboratories International Stock Price Performance5 Day Performance+5.59%1 Month Performance-12.15%3 Month Performance+12.36%6 Month Performance+30.39%Year-To-Date Performance+1.29%1 Year Performance+17.48% Receive CRL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… CRL Stock Chart for Thursday, April, 25, 2024 CRL Chart by TradingView Charles River Laboratories International Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$239.98$239.46-0.22%$244.56$237.44705,117 shs$12.33 billion04/23/2024$232.56$239.98+3.19%$242.86$236.22611,881 shs$12.36 billion04/22/2024$226.78$232.56+2.55%$232.67$225.79543,732 shs$11.98 billion04/19/2024$227.55$226.78-0.34%$230.34$225.65406,367 shs$11.68 billion04/18/2024$229.90$227.55-1.02%$233.72$223.49707,817 shs$11.72 billion04/17/2024$232.43$229.90-1.09%$233.30$229.89499,836 shs$11.84 billion Get the Latest News and Ratings for CRL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$235.93$232.43-1.48%$235.16$231.40336,008 shs$11.97 billion04/15/2024$241.34$235.93-2.24%$244.41$234.17455,432 shs$12.15 billion04/12/2024$246.42$241.34-2.06%$246.57$239.66388,509 shs$12.43 billion04/11/2024$247.49$246.42-0.43%$250.72$246.24318,607 shs$12.69 billion04/10/2024$257.24$247.49-3.79%$251.31$246.38486,666 shs$12.75 billion04/09/2024$254.90$257.24+0.92%$258.52$256.13328,437 shs$13.25 billion04/08/2024$253.10$254.90+0.71%$257.52$253.12442,617 shs$13.13 billion04/05/2024$250.66$253.10+0.97%$256.13$249.36529,686 shs$13.04 billion04/04/2024$259.54$250.66-3.42%$264.71$250.13684,723 shs$12.91 billion04/03/2024$261.64$259.54-0.80%$261.60$258.17606,359 shs$13.37 billion04/02/2024$268.73$261.64-2.64%$268.81$258.88553,639 shs$13.42 billion04/01/2024$270.95$268.73-0.82%$273.32$267.83332,511 shs$13.79 billion03/29/2024$270.93$270.95+0.01%$272.19$267.23497,507 shs$13.90 billion03/28/2024$269.37$270.93+0.58%$272.19$267.23497,507 shs$13.90 billion03/27/2024$265.43$269.37+1.48%$269.95$266.06288,859 shs$13.82 billion03/26/2024$265.49$265.43-0.02%$267.29$263.35314,809 shs$13.62 billion03/25/2024$272.57$265.49-2.60%$273.00$265.20381,046 shs$13.62 billion03/22/2024$273.43$272.57-0.31%$274.77$268.23377,604 shs$13.98 billion03/21/2024$268.17$273.43+1.96%$274.61$269.96440,854 shs$14.03 billion03/20/2024$266.51$268.17+0.62%$269.00$262.62379,814 shs$13.76 billion03/19/2024$262.13$266.51+1.67%$266.61$261.37551,461 shs$13.67 billion03/18/2024$258.97$262.13+1.22%$266.00$258.88372,566 shs$13.45 billion03/15/2024$260.64$258.97-0.64%$261.58$255.04832,745 shs$13.29 billion03/14/2024$261.18$260.64-0.21%$264.86$256.83404,572 shs$13.37 billion03/13/2024$264.12$261.18-1.11%$267.20$259.36576,621 shs$13.40 billion03/12/2024$263.09$264.12+0.39%$268.22$261.17503,347 shs$13.55 billion03/11/2024$266.97$263.09-1.45%$267.60$262.25474,441 shs$13.50 billion03/08/2024$270.27$266.97-1.22%$275.00$265.41522,908 shs$13.70 billion03/07/2024$263.43$270.27+2.60%$271.54$264.52368,302 shs$13.86 billion03/06/2024$261.27$263.43+0.83%$269.10$263.00522,528 shs$13.51 billion03/05/2024$258.92$261.27+0.91%$262.12$256.11455,538 shs$13.40 billion03/04/2024$264.38$258.92-2.07%$264.81$258.79391,419 shs$13.28 billion03/01/2024$254.19$264.67+4.12%$265.80$250.73834,558 shs$13.59 billion02/29/2024$256.73$254.19-0.99%$259.69$252.90641,572 shs$13.05 billiontop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…02/28/2024$252.95$256.73+1.49%$260.04$251.73745,194 shs$13.18 billion02/27/2024$249.65$252.95+1.32%$253.60$249.04483,233 shs$12.99 billion02/26/2024$247.71$249.65+0.78%$250.97$245.55573,123 shs$12.82 billion02/23/2024$246.86$247.71+0.34%$250.19$247.02364,333 shs$12.72 billion02/22/2024$241.10$246.86+2.39%$251.99$242.24897,851 shs$12.68 billion02/21/2024$238.94$241.10+0.90%$241.28$235.28376,254 shs$12.38 billion02/20/2024$244.96$238.94-2.46%$243.94$235.75787,280 shs$12.27 billion02/19/2024$244.96$244.96$248.67$243.13593,400 shs$12.58 billion02/16/2024$245.47$244.88-0.24%$248.67$242.92593,483 shs$12.55 billion02/15/2024$245.12$245.47+0.14%$245.97$236.391.04 million shs$12.59 billion02/14/2024$220.24$245.12+11.30%$245.41$225.001.65 million shs$12.57 billion02/13/2024$225.78$220.24-2.45%$224.87$216.50910,938 shs$11.29 billion02/12/2024$222.22$225.78+1.60%$227.67$220.03663,543 shs$11.58 billion02/09/2024$218.77$222.22+1.58%$224.61$217.13527,238 shs$11.39 billion02/08/2024$218.58$218.77+0.09%$220.59$216.44464,147 shs$11.22 billion02/07/2024$220.50$218.58-0.87%$220.81$217.89300,178 shs$11.21 billion02/06/2024$217.59$220.50+1.34%$221.18$217.36324,856 shs$11.31 billion02/05/2024$218.17$217.59-0.27%$219.82$215.40310,886 shs$11.16 billion02/02/2024$219.30$218.18-0.51%$219.63$215.06426,019 shs$11.19 billion02/01/2024$216.19$219.30+1.44%$220.33$212.52390,894 shs$11.24 billion01/31/2024$223.88$216.19-3.43%$222.96$215.76706,103 shs$11.08 billion01/30/2024$224.56$223.88-0.30%$228.52$223.60506,191 shs$11.48 billion01/29/2024$220.28$224.56+1.94%$225.16$218.43571,445 shs$11.51 billion01/26/2024$213.03$220.28+3.40%$224.03$216.35924,496 shs$11.29 billion01/25/2024$213.11$213.03-0.04%$216.80$211.23244,114 shs$10.92 billion01/24/2024$213.98$213.11-0.41%$216.05$211.26312,419 shs$10.93 billion01/23/2024$215.82$213.98-0.85%$216.05$211.48392,037 shs$10.97 billion Related Companies: Incyte Stock Price Chart Medpace Stock Price Chart ICON Public Stock Price Chart IQVIA Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart Insulet Stock Price Chart Shockwave Medical Stock Price Chart Exact Sciences Stock Price Chart Revvity Stock Price Chart DaVita Stock Price Chart Receive CRL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Charles River Laboratories International and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CRL) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.